Lv4
590 积分 2025-09-18 加入
An Industry Perspective on Key Considerations for the ICH S13 Guidance: Nonclinical Safety Evaluations of Oligonucleotide-Based Therapeutics
10天前
已完结
Effect of inclisiran on lipids in primary prevention: the ORION-11 trial
1个月前
已完结
Effect of 1 or 2 Doses of Inclisiran on Low-Density Lipoprotein Cholesterol Levels
1个月前
已完结
Recent Progress of Small Interfering RNA Delivery on the Market and Clinical Stage
1个月前
已完结
Pharmacokinetics and Pharmacodynamics of Therapeutic Proteins and Nucleic Acids
4个月前
已完结
Hydrolysis of O-, N-, and N+-glucuronide metabolites in human feces
5个月前
已关闭
In Vivo Metabolite Profiles of an N-Acetylgalactosamine–Conjugated Antisense Oligonucleotide AZD8233 Using Liquid Chromatography High-Resolution Mass Spectrometry: A Cross-Species Comparison in Animals and Humans
5个月前
已完结
Comparative Evaluation of the In Vitro Efficacy of Lanthanum Carbonate Chewable Tablets
7个月前
已完结
Systematic review of pharmacokinetics and potential pharmacokinetic interactions of flavonolignans from silymarin
8个月前
已完结
In vitro bioequivalence approach for a locally acting gastrointestinal drug: lanthanum carbonate
9个月前
已完结
皖公网安备34019202002308
